PLSE
PLSE
NASDAQ · Health Care

Pulse Biosciences Inc

$26.51
+0.56 (+2.16%)
As of Jun 24, 1:51 PM ET ·
Financial Highlights (FY 2026)
Revenue
354.1K
Net Income
-73,533,163
Gross Margin
-54.0%
Profit Margin
-20,794.6%
Rev Growth
-20.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -54.0% -54.0% 64.0% 64.0%
Operating Margin -21,982.6% -19,784.3% 8.7% 7.9%
Profit Margin -20,794.6% -19,754.8% 8.4% 7.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 354.1K 446.1K 720.89M 620.86M
Gross Profit -191,203 -240,900 461.24M 397.24M
Operating Income -77,836,103 -88,260,668 62.62M 49.27M
Net Income -73,533,163 -83,381,437 60.22M 48.91M
Gross Margin -54.0% -54.0% 64.0% 64.0%
Operating Margin -21,982.6% -19,784.3% 8.7% 7.9%
Profit Margin -20,794.6% -19,754.8% 8.4% 7.9%
Rev Growth -20.6% -20.6% -7.3% +13.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 308.01M 262.97M
Total Equity 738.41M 772.91M
D/E Ratio 0.42 0.34
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -77,325,919 -92,553,386 74.89M 60.65M
Free Cash Flow 49.96M 50.83M